Armo Biosciences Inc. (ARMO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2017 | 12-2016 | 12-2015 | |
| Assets | |||
| Current Assets | |||
| Cash & Cash Equivalents | 49,525 | 26,787 | N/A |
| TOTAL | $52,099 | $26,965 | $N/A |
| Non-Current Assets | |||
| PPE Net | 250 | 429 | N/A |
| Other Non-Current Assets | 3,843 | 507 | 0 |
| TOTAL | $4,093 | $936 | $N/A |
| Total Assets | $56,192 | $27,901 | $N/A |
| Liabilities | |||
| Current Liabilities | |||
| Accounts payable and accrued liabilities | 5,764 | 7,481 | 0 |
| Accrued Expenses | 5,714 | 1,995 | N/A |
| Other current liabilities | 32 | 101 | N/A |
| TOTAL | $11,646 | $9,615 | $N/A |
| Non-Current Liabilities | |||
| Deferred Revenues | 136 | 38 | N/A |
| Other Non-Current Liabilities | 177,077 | 109,587 | 2,488 |
| TOTAL | $177,077 | $109,587 | $N/A |
| Total Liabilities | $188,723 | $119,202 | $N/A |
| Shareholders' Equity | |||
| Shares Outstanding, K | N/A | 29,276 | N/A |
| Common Shares | 1 | 1 | N/A |
| Retained earnings | -135,354 | -92,860 | N/A |
| TOTAL | $-132,531 | $-91,301 | $N/A |
| Total Liabilities And Equity | $56,192 | $27,901 | $0 |